Morphologic and body composition changes are different in men and women on generic combination antiretroviral therapy - an observational study

Journal of Association of Physicians of India

Volumn 58, Issue 6, 2010, Pages 375-377

  Padmapriyadarsini, C ^a   Swaminathan, S ^a   Karthipriya, M J ^a   Narendran, G ^a   Menon, Pradeep Aravindan ^a   Thomas, Beena E ^a  

^a NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; GENERIC DRUG;

ADIPOSE TISSUE; ADULT; ANTHROPOMETRY; ARTICLE; BODY COMPOSITION; BODY MASS; CHEMICALLY INDUCED DISORDER; COHORT ANALYSIS; DRUG EFFECT; FEMALE; HIV ASSOCIATED LIPODYSTROPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMPEDANCE; INDIA; MALE; PATHOPHYSIOLOGY; SEX DIFFERENCE;

ADIPOSE TISSUE; ADULT; ANTHROPOMETRY; ANTI-HIV AGENTS; BODY COMPOSITION; BODY MASS INDEX; COHORT STUDIES; DRUGS, GENERIC; ELECTRIC IMPEDANCE; FEMALE; HIV INFECTIONS; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; INDIA; MALE; SEX FACTORS;

EID: 77953218641     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Saghayam S, Chaguturu SK, Kumarasamy N, Solomon S, Mayer KH, Wanke C. Lipoatrophy is the predominant presentation of HIV associated Lipodystrophy in Southern India. Clin Infect Dis 2004; 38: 646-647.
2. Pujari SN, Dravid A, Naik E, et al. Lipodystrophy and dyslipidemia among patients taking first line, World Health Organization-recommended highly active antiretroviral therapy regimens in Western India. J Acquir Immune Defic Syndr. 2005; 39:199-202.
3. van der valk M, Gisolf EH, Reiss P, et al. Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection. AIDS. 2001; 15: 847-855.
4. Swanson B, Keithley JK. Bioelectrical impedance analysis (BIA) in HIV infection: principles and clinical applications. J Assoc Nurs AIDS Care 1998; 9:49-54
5. Saghayam S, Kumarasamy N, Cecelia AJ, Solomon S, Mayer KH, Wanke C. Weight and body shape changes in a treatment naïve population after 6 months of nevirapine based generic highly active antiretroviral therapy in South India. Clin Infect Dis. 2007; 44: 295-300.
6. Galli M, Veglia F, Angarano G, et al. Gender differences in antiretroviral drug related adipose tissue alterations; Women are at higher risk than men and develop particular lipodystrophy patterns. J Acquir Immune Defic Syndr. 2007; 344: 58-61.
7. Griensven JV, Naeyer DL, Mushi T, et al. High prevalence of Lipoatrophy among patients on Stavudine containing first-line antiretroviral therapy regimens in Rwanda. Trans R Soc trop Med Hyg, 2007; 101: 793-798.
8. Lichentein KA, Ward JD, Moorman AC, et al. Clinical assessment of HIV associated lipodystrophy in an ambulatory population. AIDS. 2001; 15: 1389-1398.
9. Paton NI, Yang Y, Tha NO, Sotoh YY. Changes in facial fat in HIV-related lipoatrophy, wasting and weight gain measured by magnetic resonance imaging. HIV Clin Trials. 2007; 8: 227-234.
10. Nolan D, Mallal S. The role of nucleoside reverse transcriptase inhibitors in the fat redistribution syndrome. J HIV Ther 2004; 9: 34-40.
11. Strobel M, Muller P, Claudel P. Complete reversibility of severe nucleoside induced lipodystrophy. AIDS 1999; 13: 2606-7
12. Misra A, Madhavan BM, Vikram NK, Pandey RM, Dingra V, Luthard K. Simple anthropometric measures identify fasting hyerinsulinemia and clustering of cardiovascular risk factors in Asian Indian adolescents. Metabolism 2006; 55:1569-1573